Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Sotrovimab (brand name Xevudy) is a monoclonal antibody treatment previously used for mild-to-moderate COVID-19 in patients at high risk for severe disease
Sotrovimab (brand name Xevudy) is a monoclonal antibody treatment previously used for mild-to-moderate COVID-19 in patients at high risk for severe disease